Retheesh Das: Avoiding Unnecessary Transfusions – Why Less Can Be Safer
Retheesh Das, Nursing Officer at Madhya Pradesh Medical Science University (MPMSU), shared a post on LinkedIn:
”Avoiding Unnecessary Transfusions
Blood transfusion isn’t an automatic response – it’s a deliberate treatment.
Mastering the decision of when to hold back is essential in today’s healthcare.
The Importance of Caution
Extra transfusions aren’t harmless. They come with real dangers, such as:
- TRALI: An immune-triggered lung damage causing sudden breathing problems.
- TACO: Overloading the system with fluid, resulting in lung swelling.
- Alloimmunization: Building antibodies that mess up later transfusions or births.
- Infections: Uncommon spread of bugs like viruses or bacteria, even with checks.
- Immunomodulation: Tweaking immunity, raising chances of infections or cancer return.
- Elevated risks: More issues, longer recoveries, and higher death rates in those over-transfused.
Key Idea: Extra blood doesn’t mean superior results. Studies prove that conservative approaches often match or surpass aggressive ones.
Guidelines Backed by Research….
Red Blood Cells
• Below 7 g/dL Hb: Think about transfusing to avoid oxygen shortages.
• 7-8 g/dL Hb: Tailor to the individual’s age, health issues, and signs.
• Above 8 g/dL Hb: Usually skip it—risks typically eclipse benefits.
• Special Cases: Heart attacks, active bleeding, anemia symptoms, or risky operations.
• Reminder: Focus on the person’s condition, not just the lab result.
Plasma (FFP)
• Skip for: Slight INR rises or just needing more fluid.
• Use for: Actual bleeding tied to clotting problems.
• Instances: DIC from sepsis or injury, or huge blood loss scenarios.
Approaches to Blood Conservation (PBM)
• Boost Hb before surgery with checks and fixes like iron or vitamins.
• Cut down on needless blood draws using efficient methods.
• Embrace natural low Hb in steady patients—the body adjusts.
• Method: Give one unit, check progress, add more only if required.
Final Insight….
Holding off isn’t skimping – it’s wise practice. Strive for science-driven, individualized care that balances dangers and gains.”
Retheesh Das/LinkedIn
Stay updated with Hemostasis Today.
-
Nov 9, 2026, 09:29Veronica Sanchez: A Framework for Woman’s Health
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause